Tarsus Pharmaceuticals Company Insiders

Tarsus Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.2346) % which means that it has lost $0.2346 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5483) %, meaning that it created substantial loss on money invested by shareholders. Tarsus Pharmaceuticals' management efficiency ratios could be used to measure how well Tarsus Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.33 in 2025. Return On Capital Employed is likely to drop to -0.43 in 2025. At this time, Tarsus Pharmaceuticals' Non Current Assets Total are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 15.4 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 114 M in 2025. Common Stock Shares Outstanding is likely to drop to about 24.6 M in 2025. Net Loss is likely to gain to about (53.1 M) in 2025

Tarsus Pharmaceuticals Workforce Comparison

Tarsus Pharmaceuticals Profit Margins

The company has Profit Margin (PM) of (0.63) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.37) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.37.

Tarsus Pharmaceuticals Insider Trading History

Tarsus Pharmaceuticals Notable Stakeholders

The success or failure of an entity such as Tarsus Pharmaceuticals often depends on how effective the management is. Tarsus Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tarsus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tarsus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Tarsus Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Tarsus Pharmaceuticals. Check Tarsus Pharmaceuticals' Beneish M Score to see the likelihood of Tarsus Pharmaceuticals' management manipulating its earnings.

When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.